These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17561390)

  • 1. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
    González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
    Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of insulin-like growth factor-1 CA repeat polymorphism on breast cancer risk along with race: a meta-analysis.
    He B; Xu Y; Pan Y; Li R; Gao T; Song G; Gu L; Nie Z; Chen L; Wang S
    Gene; 2013 Aug; 525(1):92-8. PubMed ID: 23628798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Sayed-Tabatabaei FA; Coebergh JW; Hofman A; Njajou O; Stricker B; van Duijn C
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2143-6. PubMed ID: 16172223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity.
    González-Zuloeta Ladd AM; Arias-Vásquez A; Siemes C; Coebergh JW; Hofman A; Witteman J; Uitterlinden A; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jan; 43(2):371-4. PubMed ID: 17035001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Siemes C; Yazdanpanah M; Coebergh JW; Hofman A; Stricker BH; van Duijn CM
    Breast Cancer Res Treat; 2007 Mar; 101(3):299-304. PubMed ID: 16823505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
    Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
    Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.
    Rietveld I; Janssen JA; van Rossum EF; Houwing-Duistermaat JJ; Rivadeneira F; Hofman A; Pols HA; van Duijn CM; Lamberts SW
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):195-203. PubMed ID: 15272914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.
    Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O
    Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I in epithelial ovarian cancer and its role in disease progression.
    Brokaw J; Katsaros D; Wiley A; Lu L; Su D; Sochirca O; de la Longrais IA; Mayne S; Risch H; Yu H
    Growth Factors; 2007 Oct; 25(5):346-54. PubMed ID: 18236213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.
    Verheus M; McKay JD; Kaaks R; Canzian F; Biessy C; Johansson M; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2008 Nov; 112(1):109-22. PubMed ID: 18064566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
    Wagner K; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I (Igf-1) gene polymorphism in patients with non-metastatic breast cancer.
    Yaren A; Turgut S; Ayada C; Akcilar R; Degirmencioglu S; Gokoz Dogu G
    Gene; 2012 Jul; 503(2):244-7. PubMed ID: 22564703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
    Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women.
    Wen W; Gao YT; Shu XO; Yu H; Cai Q; Smith JR; Zheng W
    Int J Cancer; 2005 Jan; 113(2):307-11. PubMed ID: 15386404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.